RNU7-113P

Across TCGA pan-cancer cohorts, RNU7-113P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU7-113P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU7-113P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-113P expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LIHC, LUSC, and STAD are the cancer types where RNU7-113P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.440	0.736	.001	60	view →
LUSC	DFS	Tertile	II,III,IV	0.506	0.638	.020	48	view →
STAD	OS	Tertile	IV	0.122	0.530	.023	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	27	view →
ACC	OS	Tertile	IV	0.344	0.724	.038	18	view →
LAML	DFS	Median	All	0.527	0.249	.015	12	view →
BRCA	OS	Tertile	IV	0.323	0.645	.032	9	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →
LGG	OS	Tertile	All	0.833	0.925	.014	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU7-113P–LIHC (OS)

Open the LIHC breakdown →